An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)

Participation Deadline: 01/21/2027
Apply Now

Description

The objective of this study is to describe and compare the incidence of adverse pregnancy outcomes (spontaneous abortion/miscarriage, stillbirth) and prevalence of adverse infant outcomes (major congenital malformations [MCMs], small for gestational age [SGA]) in women with AD who are treated with dupilumab during pregnancy relative to women with AD who are not treated with dupilumab during pregnancy.